Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

NCT07515859 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07515859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07515859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Completed
Start date
May 1, 2006
Completion date
December 31, 2022
Enrollment
31,486 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer therapy-related cardiac dysfunction, heart failure, left ventricular dysfunction